Multicenter closed-loop insulin delivery study points to challenges for keeping blood glucose in a safe range by a control algorithm in adults and adolescents with type 1 diabetes from various sites

Diabetes Technology and Therapeutics

Volumn 16, Issue 10, 2014, Pages 613-622

  Zisser, Howard ^a   Renard, Eric ^b   Kovatchev, Boris ^c   Cobelli, Claudio ^d   Avogaro, Angelo ^d   Nimri, Revital ^e   Magni, Lalo ^f   Buckingham, Bruce A ^g   Chase, H Peter ^h   Doyle, Francis J ⁱ   Lum, John ^j   Calhoun, Peter ^j   Kollman, Craig ^j   Dassau, Eyal ^a,i   Farret, Anne ^b   Place, Jerome ^b   Breton, Marc ^c   Anderson, Stacey M ^c   Dalla Man, Chiara ^d   Del Favero, Simone ^d   Bruttomesso, Daniela ^d   Filippi, Alessio ^d   Scotton, Rachele ^d   Phillip, Moshe ^e   Atlas, Eran ^e   Muller, Ido ^e   Miller, Shahar ^e   Toffanin, Chiara ^f   Raimondo, Davide Martino ^f   De Nicolao, Giuseppe ^f   Beck, Roy W ^j   Jovanovic, Lois ^a   Wollitzer, Alison ^a   Bevier, Wendy ^a   Castorino, Kristin ^a   Markova, Kateryna ^a   Wiley, Jacqueline ^a   Beveridge, Erin ^a   Santibanez, Nicolas ^a   Sales, Alexandra ^a   Bradley, Maia ^a   Castorino, Adam ^a   Demartini, Susan ^c   Brown, Sue ^c   Clarke, William ^c   Patek, Stephen ^c   Keith Hynes, Patrick ^c   Hughes Karvetski, Colleen ^c   McElwee, Molly ^c   Oliveri, Mary ^c   Wakeman, Christian ^c   Pelletier, Marie Josee ^b   Chevassus, Hugues ^b   Oron, Tal ^e   Farfel, Alon ^e   Demol, Sharon ^e   Mel, Eran ^e   Ben Ari, Tal ^e   Gilon, Michael ^e   Parnes, Ayele ^e   Hamou, Alona ^e   Hermon, Orna ^e   Shiovitch Mantzuri, Galit ^e   Fayman, Galia ^e   Maran, Alberto ^d   Schiavon, Michele ^d   Vistenin, Roberto ^d   Mancini, Simone ^f   Wilson, Darrell M ^g   Benassi, Kari ^g   Clinton, Paula ^g   Harris, Breanne P ^g   Shanmugham, Satya ^g   Caswell, Kimberly ^g   Maahs, David M ^h   Slover, Robert ^h   Sullivan, Sally ^h   Messer, Laurel ^h   Gage, Victoria ^h   Realsen, Jaime ^h   Westfall, Emily ^h   Goettle, Hannah ^h   Sibayan, Judy ^j   Njeru, Nelly M ^j   Sauer, Werner ^j   Pickup, John C ^k   Hirsch, Irl ^k   Wolpert, Howard ^k   more..

^a SANSUM DIABETES RESEARCH INSTITUTE   (United States)

^b MONTPELLIER UNIVERSITY HOSPITAL   (France)

^c UNIVERSITY OF VIRGINIA   (United States)

^d UNIVERSITY OF PADOVA   (Italy)

^e TEL AVIV UNIVERSITY   (Israel)

^f UNIVERSITY OF PAVIA   (Italy)

^g STANFORD UNIVERSITY   (United States)

^h UNIVERSITY OF COLORADO DENVER   (United States)

ⁱ University of California   (United States)

^j JAEB CENTER FOR HEALTH RESEARCH   (United States)

^k Stanford University ^*

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; ANTIDIABETIC AGENT; CARBOHYDRATE DIET; GLUCOSE BLOOD LEVEL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADOLESCENT; ADULT; ALGORITHM; ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; CHILD; CLINICAL EFFECTIVENESS; CLOSED LOOP INSULIN DELIVERY SYSTEM; DEVICE SAFETY; DIABETIC KETOACIDOSIS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE SENSOR; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN INFUSION; INSULIN PUMP; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ARTIFICIAL PANCREAS; BLOOD; CARBOHYDRATE DIET; CLINICAL TRIAL; DIABETES MELLITUS, TYPE 1; MEAL; METABOLISM; PATIENT SAFETY; PHYSIOLOGIC MONITORING; PILOT STUDY; POSTPRANDIAL STATE; REPRODUCIBILITY; SECRETION (PROCESS); TIME; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ALGORITHMS; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; DIETARY CARBOHYDRATES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MEALS; MONITORING, PHYSIOLOGIC; PANCREAS, ARTIFICIAL; PATIENT SAFETY; PILOT PROJECTS; POSTPRANDIAL PERIOD; REPRODUCIBILITY OF RESULTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84907485182     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2014.0066     Document Type: Article

References (38)

1. Cobelli C, Renard E, Kovatchev B: Artificial pancreas: past, present, future. Diabetes 2011;60:2672-2682.
2. Juvenile Diabetes Research Foundation: Emerging technologies in diabetes research. The JDRF e-Newsletter 2006;(Sept):10.
3. Abbes IB, Richard PY, Lefebvre MA, Guilhem I, Poirier JY: A closed-loop artificial pancreas using a proportional integral derivative with double phase lead controller based on a new nonlinear model of glucose metabolism. J Diabetes Sci Technol 2013;7:699-707.
4. O'Grady MJ, Retterath AJ, Keenan DB, Kurtz N, Cantwell M, Spital G, Kremliovsky MN, Roy A, Davis EA, Jones TW, Ly TT: The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:2182-2187.
5. Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes 2006;55:3344-3350.
6. Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care 2008;31:934-939.
7. Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ 2011;342:d1855.
8. Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla Man C, Facchinetti A, Magni L, De Nicolao G, Place J, Farret A: Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol 2010;4:1374-1381.
9. Parker R, Doyle F III, Peppas N: A model-based algorithm for blood glucose control in type 1 diabetic patients. IEEE Trans Biomed Eng 1999;46:148-157.
10. Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M: MDLogic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care 2010;33:1072-1076.
11. Breton M, Farret A, Bruttomesso D, Anderson S, Magni L, Patek S, Dalla Man C, Place J, Demartini S, Del Favero S, Toffanin C, Hughes-Karvetski C, Dassau E, Zisser H, Doyle FJ 3rd, De Nicolao G, Avogaro A, Cobelli C, Renard E, Kovatchev B: Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes 2012;61:2230-2237.
12. Elleri D, Allen JM, Kumareswaran K, Leelarathna L, Nodale M, Caldwell K, Cheng P, Kollman C, Haidar A, Murphy HR, Wilinska ME, Acerini CL, Dunger DB, Hovorka R: Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013;36:838-844.
13. Russell SJ, El-Khatib FH, Nathan DM, Magyar KL, Jiang J, Damiano ER: Blood glucose control in type 1 diabetes with a bihormonal bionic endocrine pancreas. Diabetes Care 2012;35:2148-2155.
14. Weinzimer SA, Sherr JL, Cengiz E, Kim G, Ruiz JL, Carria L, Voskanyan G, Roy A, Tamborlane WV: Effect of pramlintide on prandial glycemic excursions during closedloop control in adolescents and young adults with type 1 diabetes. Diabetes Care 2012;35:1994-1999.
15. Steil GM, Palerm CC, Kurtz N, Voskanyan G, Roy A, Paz S, Kandeel FR: The effect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab 2011;96: 1402-1408.
16. El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER: A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med 2010;2:27ra27.
17. El-Khatib FH, Russell SJ, Magyar KL, Sinha M, McKeon K, Nathan DM, Damiano ER: Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes. J Clin Endocrinol Metab 2014;99:1701-1711.
18. Turksoy K, Bayrak ES, Quinn L, Littlejohn E, Cinar A: Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. Diabetes Technol Ther 2013;15:386-400.
19. Nimri R, Danne T, Kordonouri O, Atlas E, Bratina N, Biester T, Avbelj M, Miller S, Muller I, Phillip M, Battelino T: The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial. Pediatr Diabetes 2013;14:159-167.
20. Phillip M, Battelino T, Atlas E, Kordonouri O, Bratina N, Miller S, Biester T, Stefanija MA, Muller I, Nimri R, Danne T: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013;368: 824-833.
21. Dassau E, Zisser H, Palerm CC, Buckingham BA, Jovanovic L, Doyle F: Modular artificial B-cell system: a prototype for clinical research. J Diabetes Sci Technol 2008; 2:863-872.
22. Kovatchev B, Patek S, Dassau E, Doyle FJ III, Magni L, De Nicolao G, Cobelli C; the Juvenile Diabetes Research Foundation Artificial Pancreas Consortium: Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol 2009;3:1058-1065.
23. Patek SD, Magni L, Dassau E, Karvetski C, Toffanin C, De Nicolao G, Del Favero S, Breton M, Man CD, Renard E, Zisser H, Doyle FJ 3rd, Cobelli C, Kovatchev BP: Modular closed-loop control of diabetes. IEEE Trans Biomed Eng 2012;59:2986-2999.
24. Magni L, Raimondo DM, Bossi L, Dalla Man C, De Nicolao G, Kovatchev B, Cobelli C: Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Technol 2007;1:804-812.
25. Hughes CS, Patek SD, Breton MD, Kovatchev BP: Hypoglycemia prevention via pump attenuation and red-yellowgreen "traffic" lights using continuous glucose monitoring and insulin pump data. J Diabetes Sci Technol 2010;4:1146-1155.
26. Cobelli C, Renard E, Kovatchev BP, Keith-Hynes P, Ben Brahim N, Place J, Del Favero S, Breton M, Farret A, Bruttomesso D, Dassau E, Zisser H, Doyle FJ 3rd, Patek SD, Avogaro A: Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care 2012;35: e65-e67.
27. Kovatchev BP, Renard E, Cobelli C, Zisser HC, Keith-Hynes P, Anderson SM, Brown SA, Chernavvsky DR, Breton MD, Farret A, Pelletier MJ, Place J, Bruttomesso D, Del Favero S, Visentin R, Filippi A, Scotton R, Avogaro A, Doyle FJ: Feasibility of outpatient fully integrated closedloop control: first studies of wearable artificial pancreas. Diabetes Care 2013;36:1851-1858.
28. Renard E, Cobelli C, Kovatchev BP. Closed loop developments to improve glucose control at home. Diabetes Res Clin Pract 2013;102:79-85.
29. Christiansen M, Bailey T, Watkins E, Liljenquist D, Price D, Nakamura K, Boock R, Peyser T: A new-generation continuous glucose monitoring system: improved accuracy and reliability compared with a previous-generation system. Diabetes Technol Ther 2013;15:881-888.
30. Renard E, Guerci B, Leguerrier AM, Boizel R: Lower rate of initial failures and reduced occurrence of adverse events with a new catheter model for continuous subcutaneous insulin infusion: prospective, two-period, observational, multicenter study. Diabetes Technol Ther 2010;12:769-773.
31. Elleri D, Allen JM, Biagioni M, Kumareswaran K, Leelarathna L, Caldwell K, Nodale M, Wilinska ME, Acerini CL, Dunger DB, Hovorka R: Evaluation of a portable ambulatory prototype for automated overnight closed-loop insulin delivery in young people with type 1 diabetes. Pediatr Diabetes 2012;13:449-453.
32. Mauseth R, Hirsch IB, Bollyky J, Kircher R, Matheson D, Sanda S, Greenbaum C: Use of a "fuzzy logic" controller in a closed-loop artificial pancreas. Diabetes Technol Ther 2013;15:628-633.
33. Luijf YM, DeVries JH, Zwinderman K, Leelarathna L, Nodale M, Caldwell K, Kumareswaran K, Elleri D, Allen JM, Wilinska ME, Evans ML, Hovorka R, Doll W, Ellmerer M, Mader JK, Renard E, Place J, Farret A, Cobelli C, Del Favero S, Dalla Man C, Avogaro A, Bruttomesso D, Filippi A, Scotton R, Magni L, Lanzola G, Di Palma F, Soru P, Toffanin C, De Nicolao G, Arnolds S, Benesch C, Heinemann L: Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care 2013;36:3882-3887.
34. Smart CEM, Evans M, O'Connell SM, McElduff P, Lopez PE, Jones TWJ, Davis EA, King BR: Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care 2013;36:3897-3902.
35. Hinshaw L, Dalla Man C, Nandy DK, Saad A, Bharucha AE, Levine JA, Rizza RA, Basu R, Carter RE, Cobelli C, Kudva YC, Basu A: Diurnal pattern of insulin action in type 1 diabetes: implications for a closed-loop system. Diabetes 2013;62:2223-2229.
36. Bondia J, Dassau E, Zisser H, Calm R, Vehí J, Jovanovi-c L, Doyle FJ 3rd: Coordinated basal-bolus infusion for tighter postprandial glucose control in insulin pump therapy. J Diabetes Sci Technol 2009;3:89-97.
37. Del Favero S, Bruttomesso D, Di Palma F, Lanzola G, Visentin R, Filippi A, Scotton R, Toffanin C, Messori M, Scarpellini S, Keith-Hynes P, Kovatchev BP, Devries JH, Renard E, Magni L, Avogaro A, Cobelli C; AP@home Consortium: First use of model predictive control in outpatient wearable artificial pancreas. Diabetes Care 2014;37: 1212-1215.
38. Renard E, Cobelli C, Zisser HC, Kovatchev BP: Artificial pancreas goes outpatient: a new diabetes ecosystem. J Diabetes Sci Technol 2013;7:1411-1415.